| PCOS | Polycystic ovary syndrome |
| NIH | National Institutes of Health |
| AES | Androgen Excess Society |
| CLD | Chronic liver disease |
| NAFLD | Nonalcoholic fatty liver disease |
| MR | Mendelian randomization |
| NASH | Nonalcoholic steatohepatitis |
| SHBG | Sex hormone binding globulin |
| OS | Oxidative stress |
| ROS | Reactive oxygen species |
| GCs | Granulosa cells |
| FF | Follicular fluid |
| IR | Insulin resistance |
| SOC3 | Suppressor of cytokine signaling 3 |
| CRP | C-reactive protein |
| LH | Luteinizing hormone |
| SNPs | Single-nucleotide polymorphisms |
| BMI | Body mass index |
| FGF-21 | Fibroblast growth factor 21 |
| HPS | Hepassocin |
| HOMA-IR | Homeostatic Model Assessment for Insulin Resistance |
| PCSK9i | Proprotein convertase subtilisin/kexin type 9 inhibitor |
| DEG | Differentially expressed genes |
| LDLR | Low-density lipoprotein receptors |
| MAFLD | Metabolic-associated fatty liver disease |
| PNPLA3 | Patatin-like phospholipase domain-containing three genes |
| GLP-1 | Glucagon-like peptide-1 |
| MI | Myo-inositol |
| GLP- 1RA | Glucagon-like peptide-1 receptor agonist |
| DCI | D-chiro-inositol |
| OCs | Oral contraceptives |
| DHT | Dihydrotestosterone |
| SiRNA | Small interfering RNA |
| MiRNA | MicroRNA |
| LncRNA | Long non-coding RNA |
| CircRNA | Circular RNA |